A protein that helps cancer grow could become an unlikely ally in treating it, with laboratory and mouse experiments showing that activating it in engineered immune cells curbs tumor growth. Colorectal cancer has become the leading cause of cancer-related death…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.